Exact Mass: 623.2929956

Exact Mass Matches: 623.2929956

Found 21 metabolites which its exact mass value is equals to given mass value 623.2929956, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Leukotriene C5

(5S,6R,7E,9E,11Z,14Z,17Z)-6-{[(2R)-2-{[(4R)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-2-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl]sulphanyl}-5-hydroxyicosa-7,9,11,14,17-pentaenoic acid

C30H45N3O9S (623.287636)


Leukotriene C5 is a slow reacting substance derived from eicosapentaenoic acid.Leukotriene C5 has similar biological activity on the isolated guinea pig ileum but is less potent than is leukotriene C4. Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. Leukotriene C5 is a slow reacting substance derived from eicosapentaenoic acid.Leukotriene C5 has similar biological activity on the isolated guinea pig ileum but is less potent than is leukotriene C4.

   

2-O-Caffeoyl-maslinic acid

2-O-Caffeoyl-maslinic acid

C39H43O7 (623.3008628)


   
   

15dPGJ2-GS

11-oxo-9-(S-glutathionyl)-5Z,12E,14E-prostatetraenoic acid

C30H45N3O9S (623.287636)


   

N,N-Bis[4-(1-napthalenyl)phenyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenamine

N,N-Bis[4-(1-napthalenyl)phenyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenamine

C44H38BNO2 (623.2995438)


   

Triamcinolone Benetonide

Triamcinolone Benetonide

C35H42FNO8 (623.2894304)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid

   

Retaspimycin hydrochloride

Retaspimycin hydrochloride

C31H46ClN3O8 (623.2973266)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

15-deoxy-Delta12,14-Prostaglandin J2 Glutathione

15-deoxy-Delta12,14-Prostaglandin J2 Glutathione

C30H45N3O9S (623.287636)


   

(S)-Tetrahydrofuran-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-amino-2-oxoethyl)-2,3-dihydro-1H-inden-1-YL)-2-benzyl-3-oxo-2,3-dihydro-1H-pyrrol-2-YL)-3-hydroxy-1-phenylbutan-2-ylcarbamate

(S)-Tetrahydrofuran-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-amino-2-oxoethyl)-2,3-dihydro-1H-inden-1-YL)-2-benzyl-3-oxo-2,3-dihydro-1H-pyrrol-2-YL)-3-hydroxy-1-phenylbutan-2-ylcarbamate

C37H41N3O6 (623.2995206)


   

leukotriene C4(2-)

leukotriene C4(2-)

C30H45N3O9S-2 (623.287636)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-[(3R)-1-(phenylmethyl)-3-pyrrolidinyl]-4-[3-(3-pyridinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-[(3R)-1-(phenylmethyl)-3-pyrrolidinyl]-4-[3-(3-pyridinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

C36H41N5O3S (623.2929956)


   

(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-[(3S)-1-(phenylmethyl)-3-pyrrolidinyl]-4-[3-(3-pyridinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-[(3S)-1-(phenylmethyl)-3-pyrrolidinyl]-4-[3-(3-pyridinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

C36H41N5O3S (623.2929956)


   

(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-[(3R)-1-(phenylmethyl)-3-pyrrolidinyl]-4-[3-(3-pyridinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-[(3R)-1-(phenylmethyl)-3-pyrrolidinyl]-4-[3-(3-pyridinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

C36H41N5O3S (623.2929956)


   
   

leukotriene C4(2-)

leukotriene C4(2-)

C30H45N3O9S (623.287636)


The leukotriene anion that is the dianion of leukotriene C4 arising from deprotonation of the three carboxy groups and protonation of the glutamyl alpha-amino group.

   
   
   

5-{3-[(2-{[2-amino-1-hydroxy-3-(2-hydroxybenzoyloxy)propylidene]amino}-1-hydroxypropylidene)amino]-n-hydroxypropanamido}-n-(1-hydroxy-2-oxopiperidin-3-yl)-2-(methylamino)pentanimidic acid

5-{3-[(2-{[2-amino-1-hydroxy-3-(2-hydroxybenzoyloxy)propylidene]amino}-1-hydroxypropylidene)amino]-n-hydroxypropanamido}-n-(1-hydroxy-2-oxopiperidin-3-yl)-2-(methylamino)pentanimidic acid

C27H41N7O10 (623.2914766)


   

5-[3-({2-[(1,3-dihydroxy-2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}propylidene)amino]-1-hydroxypropylidene}amino)-n-hydroxypropanamido]-n-(1-hydroxy-2-oxopiperidin-3-yl)-2-(methylamino)pentanimidic acid

5-[3-({2-[(1,3-dihydroxy-2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}propylidene)amino]-1-hydroxypropylidene}amino)-n-hydroxypropanamido]-n-(1-hydroxy-2-oxopiperidin-3-yl)-2-(methylamino)pentanimidic acid

C27H41N7O10 (623.2914766)


   

5-(3-{[(2s)-2-{[(2r)-2-amino-1-hydroxy-3-(2-hydroxybenzoyloxy)propylidene]amino}-1-hydroxypropylidene]amino}-n-hydroxypropanamido)-n-[(3s)-1-hydroxy-2-oxopiperidin-3-yl]-2-(methylamino)pentanimidic acid

5-(3-{[(2s)-2-{[(2r)-2-amino-1-hydroxy-3-(2-hydroxybenzoyloxy)propylidene]amino}-1-hydroxypropylidene]amino}-n-hydroxypropanamido)-n-[(3s)-1-hydroxy-2-oxopiperidin-3-yl]-2-(methylamino)pentanimidic acid

C27H41N7O10 (623.2914766)


   

5-(3-{[(2s)-2-{[(2r)-1,3-dihydroxy-2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}propylidene]amino}-1-hydroxypropylidene]amino}-n-hydroxypropanamido)-n-[(3s)-1-hydroxy-2-oxopiperidin-3-yl]-2-(methylamino)pentanimidic acid

5-(3-{[(2s)-2-{[(2r)-1,3-dihydroxy-2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}propylidene]amino}-1-hydroxypropylidene]amino}-n-hydroxypropanamido)-n-[(3s)-1-hydroxy-2-oxopiperidin-3-yl]-2-(methylamino)pentanimidic acid

C27H41N7O10 (623.2914766)